Alira Health

Alira Health

Alira Health Partners With Col·legi de Metges de Barcelona

We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.

News
Published on:
September 8, 2023
Through the collaboration with the CoMB, one of the most relevant organizations in Catalonia, we will further demonstrate our commitment to helping start-ups develop strategies for successful market access.
Chus Castillo Partner Consulting Iberia

CoMB offers advice and support for health professionals who are developing innovative projects through its Innovation and Entrepreneurship Area. The main goals of this area are to foster innovation, stimulate entrepreneurship, and promote networking and collaboration within the medical sector. One of the key partnership elements will be a collaboration on the Healthcare Investment Forum, the flagship event of the Innovation and Entrepreneurship Area that promotes business angels’ investment in start-ups in Catalonian ecosystem.

As a stakeholder in Catalonia’s healthcare ecosystem, Alira Health is committed to promote and accelerate market access for entrepreneurship projects in this region. Alira Health’s Barcelona office, with a team of over 100 experts, provides extensive experience in demonstrating our clients’ value and realizing the commercial opportunity for their innovative solutions.

“This partnership is a great opportunity for Alira Health to accelerate our support for the growing start-up network in Catalonia. Through the collaboration with the CoMB, one of the most relevant organizations in Catalonia, we will further demonstrate our commitment to helping start-ups develop strategies for successful market access,” stated Chus Castillo, Partner Consulting Iberia.

“Thanks to the partnership with Alira Health, CoMB will be able to further foster entrepreneurship within the biomedical sector and help start-ups to have a better go-to-market strategy,” said Georgina Sorrosal, Innovation and Entrepreneurship Area Director at CoMB.

Related news

Articles July 4, 2024
Navigating Market Access for Rare Diseases: The Potential of Real-World Evidence
Our experts answer common questions about the strategic need for real-world evidence to drive market access for rare diseases.
Market Access Rare Disease Real-World Evidence (RWE)
Case Studies June 27, 2024
A Multinational Pharma Targeting Myasthenia Gravis Garners Payer Advice on Market Access
Our client sought to incorporate early payer advice on the MG clinical trial design, identify evidence gaps, and provide insights on the overall development program for the asset.
Market Access Myasthenia Gravis (MG) Rare Disease
Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
Events February 1, 2024
2023 BioRegion Report Presentation
Biotech Spain
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.